Complete AV Block in Vaccinated COVID-19 Patient
Background. Coronavirus 2019 (COVID-19) was initially identified approximately in December 2019 at Wuhan, China, as patients presented with vague prodromal and respiratory symptoms. With the developing investigation of its clinical manifestation, cardiac symptoms have been widely reported including...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Case Reports in Cardiology |
| Online Access: | http://dx.doi.org/10.1155/2022/9371818 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832550937631129600 |
|---|---|
| author | Kevin Lee Osman Rahimi Neelesh Gupta Chowdhury Ahsan |
| author_facet | Kevin Lee Osman Rahimi Neelesh Gupta Chowdhury Ahsan |
| author_sort | Kevin Lee |
| collection | DOAJ |
| description | Background. Coronavirus 2019 (COVID-19) was initially identified approximately in December 2019 at Wuhan, China, as patients presented with vague prodromal and respiratory symptoms. With the developing investigation of its clinical manifestation, cardiac symptoms have been widely reported including acute coronary syndromes, myocarditis, arrhythmias, heart failure, and cardiac arrest. Case Summary. An 84 year-old male with history of coronary artery disease, hypertension, and hyperlipidemia presented to an outside urgent care with prodromal symptoms. The patient had received the second Pfizer vaccine three months prior. This presentation, he was found to be COVID-19 positive as well as bradycardic with a complete AV block. He was transferred to a tertiary center for further evaluation and management. However, after transfer, the patient refused further invasive cardiac interventions and after medical therapy was discharged home in complete AV block. Discussion. We report a novel case of a Pfizer-vaccinated patient whose initial presenting symptoms of COVID-19 included a complete AV block as well as the challenges and difficulties in approaching such patients. Although this patient’s etiology of his complete AV block may result from multiple factors, given the acuity in setting of concurrent COVID-19 infections, top differentials include viral myocarditis, COVID-19-induced Takotsubo cardiomyopathy complicated by a complete AV-block, or a direct conduction pathway infection. Management of patients should focus on a multidisciplinary approach, and prevention is critical via vaccination. |
| format | Article |
| id | doaj-art-d1b80605cc8b470894d3481ea7876e2e |
| institution | Kabale University |
| issn | 2090-6412 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Cardiology |
| spelling | doaj-art-d1b80605cc8b470894d3481ea7876e2e2025-02-03T06:05:24ZengWileyCase Reports in Cardiology2090-64122022-01-01202210.1155/2022/9371818Complete AV Block in Vaccinated COVID-19 PatientKevin Lee0Osman Rahimi1Neelesh Gupta2Chowdhury Ahsan3Department of Internal MedicineDepartment of Internal MedicineDepartment of CardiologyDepartment of CardiologyBackground. Coronavirus 2019 (COVID-19) was initially identified approximately in December 2019 at Wuhan, China, as patients presented with vague prodromal and respiratory symptoms. With the developing investigation of its clinical manifestation, cardiac symptoms have been widely reported including acute coronary syndromes, myocarditis, arrhythmias, heart failure, and cardiac arrest. Case Summary. An 84 year-old male with history of coronary artery disease, hypertension, and hyperlipidemia presented to an outside urgent care with prodromal symptoms. The patient had received the second Pfizer vaccine three months prior. This presentation, he was found to be COVID-19 positive as well as bradycardic with a complete AV block. He was transferred to a tertiary center for further evaluation and management. However, after transfer, the patient refused further invasive cardiac interventions and after medical therapy was discharged home in complete AV block. Discussion. We report a novel case of a Pfizer-vaccinated patient whose initial presenting symptoms of COVID-19 included a complete AV block as well as the challenges and difficulties in approaching such patients. Although this patient’s etiology of his complete AV block may result from multiple factors, given the acuity in setting of concurrent COVID-19 infections, top differentials include viral myocarditis, COVID-19-induced Takotsubo cardiomyopathy complicated by a complete AV-block, or a direct conduction pathway infection. Management of patients should focus on a multidisciplinary approach, and prevention is critical via vaccination.http://dx.doi.org/10.1155/2022/9371818 |
| spellingShingle | Kevin Lee Osman Rahimi Neelesh Gupta Chowdhury Ahsan Complete AV Block in Vaccinated COVID-19 Patient Case Reports in Cardiology |
| title | Complete AV Block in Vaccinated COVID-19 Patient |
| title_full | Complete AV Block in Vaccinated COVID-19 Patient |
| title_fullStr | Complete AV Block in Vaccinated COVID-19 Patient |
| title_full_unstemmed | Complete AV Block in Vaccinated COVID-19 Patient |
| title_short | Complete AV Block in Vaccinated COVID-19 Patient |
| title_sort | complete av block in vaccinated covid 19 patient |
| url | http://dx.doi.org/10.1155/2022/9371818 |
| work_keys_str_mv | AT kevinlee completeavblockinvaccinatedcovid19patient AT osmanrahimi completeavblockinvaccinatedcovid19patient AT neeleshgupta completeavblockinvaccinatedcovid19patient AT chowdhuryahsan completeavblockinvaccinatedcovid19patient |